finance-abhi

EMCURE PHARMA

Emcure Pharmaceuticals is a leading Indian pharmaceutical company dedicated to the research, development, production, and global distribution of a wide range of pharmaceutical products across various critical therapeutic areas. Emphasizing research and development (R&D), Emcure offers a diverse product portfolio that includes oral medications, injectables, and biotherapeutics. This extensive range has enabled the company to penetrate markets in over 70 countries, with a strong presence in India, Europe, and Canada.

Ranked 13th in domestic sales among Indian pharmaceutical companies for the MAT FY 2024, Emcure Pharmaceuticals also holds the 4th largest market share in its covered markets for the same period. Notably, it is the leading pharmaceutical company in the gynecology and HIV antiviral therapeutic areas for MAT FY 2024. As of March 31, 2024, the company employed 548 qualified scientists and operated five dedicated R&D facilities in India. By the same date, Emcure Pharmaceuticals had been granted 220 patents, with 30 patent applications pending in various countries, and had submitted 102 drug master files (DMFs) for APIs to the U.S. Food and Drug Administration (USFDA).

Emcure Pharmaceuticals operates 13 manufacturing facilities across India. The company has experienced significant sales growth in the domestic market, with sales in India accounting for 48.28% of its total revenue from operations during FY 2024.

Emcure Pharma’s IPO Details

Signature Global IPO Details
Emcure Pharma IPO Dates
3 – 5 July 2024
Emcure Pharma Issue Price
INR 960 – 1,008 per share (Employee Discount – INR 90 per share)
Fresh issue
INR 800 crore
Offer For Sale
1,14,28,839 shares (INR 1,097.17 – 1,152.03 crore)
Total IPO Size
INR 1,952.03 crore
Minimum bid (size)
14 shares (INR 14,112)
Face Value
INR 10 per share
Retail Allocation
35%
Listing On
BSE, NSE

Emcure Pharma's Financial Performance

Signature Global Financial Performance

FY22

FY23

FY24

Revenue

5,855.39

5,985.81

6,658.25

Expenses

4,946.31

5,278.36

5,978.08

Net income

702.56

561.85

527.58

Margin (%)

12.00

9.39

7.92

Figures in INR Crore unless specified otherwise

finance-abhi

Get the latest IPO and finance  news and stay informed about market trends and investment opportunities with Finance Abhi.

Follow Us